CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer

A small subset tumor cells, known as tumor initiating cells (TICs) are responsible for tumor recurrence. Targeting drug loaded nanoparticles to CD133 protein expressed on TICs leads to inhibition of tumor recurrence.78